CLN — Celon Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Celon Pharma SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	44	228	165	115	75.1
Net Total Accounts Receivable
Net Total Receivables	41	27.2	33.7	48.2	52
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	119	279	238	190	160
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	331	329	342	334	312
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	532	707	643	569	544
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	114	86.4	116	86.3	66.9
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	187	153	163	124	98.6
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	345	554	480	446	445
Total Liabilities & Shareholders' Equity	532	707	643	569	544
Total Common Shares Outstanding